Harbinger Research Issues Correction Notice for Research Report issued today pertaining to Xcelerate, Inc. (OTCQB: XCRT)
ATLANTA, GA / ACCESSWIRE / June 4, 2024 / Harbinger Research, a respected equity research firm, today issued a correction to its recent report on Xcelerate, Inc. (OTCQB:XCRT). The correction addresses a clerical error pertaining to the revenue forecast model presented on the front page of its report. Upon review, it was discovered that Harbinger […]
Xcelerate, Inc. Addresses Concerns About Recently Released Research Report
MAULDIN, SC / ACCESSWIRE / June 4, 2024 / Xcelerate, Inc. (OTCQB:XCRT) today announced that it has become aware of an independent research report released by Harbinger Research earlier in the day that contains erroneous information about the Company and has reached out to the author of the report to advise of the same. Mike […]
Harbinger Research Publishes Coverage Initiation Report on Xcelerate, Inc., a Rapidly Growing Medical AI Technology, Healthcare Services, and Skin Care Products Company
Prepared by Brian R. Connell, CFA, the report offers an in-depth analysis of the Company’s business, industry, and growth opportunities as well as an analysis of its shares’ potential future value ATLANTA, GA / ACCESSWIRE / June 4, 2024 / Harbinger Research, LLC an independent equity research firm with a focus on the small cap […]
The Harbinger Report for Xcelerate, Inc. – (XCRT – OTCQB)
Harbinger_Report_Corrected Mauldin, SC, Jan. 25, 2022 (GLOBE NEWSWIRE) — Xcelerate, Inc. (OTC Pink: XCRT) today announced that it has filed a Supplemental Report with OTC Markets to remove the “shell’ status symbol from the OTC Markets webpage. “As a result of the Company’s recent Form 1-A filing with the SEC we believe that Xcelerate is […]